LICENSE AGREEMENTLicense Agreement • June 12th, 2009 • Abaxis Inc • In vitro & in vivo diagnostic substances • Massachusetts
This license agreement provides Abaxis the co-exclusive opportunity to utilize these technologies to expand the Abaxis product portfolio and enter on a large scale the professional veterinary rapid diagnostic market. This includes point of care tests for infectious diseases, hormones and therapeutic drugs. The total market for these types of tests in the animal health and laboratory animal research is estimated to be over $100,000,000 in the United States alone.
